25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

HOFBF (Hofseth BioCare ASA) Stock Analysis
Buy, Hold or Sell?

Let's analyze Hofseth BioCare ASA together

I guess you are interested in Hofseth BioCare ASA. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – Hofseth BioCare ASA’s Financial Insights
  • 📈 Technical Analysis (TA) – Hofseth BioCare ASA’s Price Targets

I'm going to help you getting a better view of Hofseth BioCare ASA. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Hofseth BioCare ASA

I send you an email if I find something interesting about Hofseth BioCare ASA.

1. Quick Overview

1.1. Quick analysis of Hofseth BioCare ASA (30 sec.)










1.2. What can you expect buying and holding a share of Hofseth BioCare ASA? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.01
Expected worth in 1 year
$0.02
How sure are you?
36.7%

+ What do you gain per year?

Total Gains per Share
$0.00
Return On Investment
3.0%

For what price can you sell your share?

Current Price per Share
$0.16
Expected price per share
$0.1 - $0.17
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Hofseth BioCare ASA (5 min.)




Live pricePrice per Share (EOD)
$0.16
Intrinsic Value Per Share
$0.21 - $0.26
Total Value Per Share
$0.22 - $0.27

2.2. Growth of Hofseth BioCare ASA (5 min.)




Is Hofseth BioCare ASA growing?

Current yearPrevious yearGrowGrow %
How rich?$5.7m$1.6m$9.1m84.4%

How much money is Hofseth BioCare ASA making?

Current yearPrevious yearGrowGrow %
Making money-$2.9m-$1.3m-$1.5m-53.7%
Net Profit Margin-48.4%-58.1%--

How much money comes from the company's main activities?

2.3. Financial Health of Hofseth BioCare ASA (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#661 / 908

Most Revenue
#341 / 908

Most Profit
#318 / 908

Most Efficient
#471 / 908
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Hofseth BioCare ASA?

Welcome investor! Hofseth BioCare ASA's management wants to use your money to grow the business. In return you get a share of Hofseth BioCare ASA.

First you should know what it really means to hold a share of Hofseth BioCare ASA. And how you can make/lose money.

Speculation

The Price per Share of Hofseth BioCare ASA is $0.155. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Hofseth BioCare ASA.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Hofseth BioCare ASA, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.01. Based on the TTM, the Book Value Change Per Share is $0.00 per quarter. Based on the YOY, the Book Value Change Per Share is $0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Hofseth BioCare ASA.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.01-6.2%-0.01-4.6%0.00-1.6%-0.01-3.9%0.00-3.0%
Usd Book Value Change Per Share-0.01-6.2%0.000.7%0.001.0%0.00-0.4%0.000.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.01-6.2%0.000.7%0.001.0%0.00-0.4%0.000.3%
Usd Price Per Share0.10-0.17-0.81-0.64-0.43-
Price to Earnings Ratio-2.60--6.89--34.90--25.68--17.12-
Price-to-Total Gains Ratio-10.44--16.94-9,588.34-1,869.24-1,869.24-
Price to Book Ratio7.11-6.64-330.53-98.06-65.37-
Price-to-Total Gains Ratio-10.44--16.94-9,588.34-1,869.24-1,869.24-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.155
Number of shares6451
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (6451 shares)7.43-4.20
Gains per Year (6451 shares)29.71-16.80
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1030200-17-27
2059500-34-44
3089800-50-61
401191100-67-78
501491400-84-95
601781700-101-112
702082000-118-129
802382300-134-146
902672600-151-163
1002972900-168-180

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%2.010.00.016.7%2.018.00.010.0%2.028.00.06.7%2.028.00.06.7%
Book Value Change Per Share1.03.00.025.0%4.08.00.033.3%6.014.00.030.0%11.019.00.036.7%11.019.00.036.7%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.030.00.0%0.00.030.00.0%
Total Gains per Share1.03.00.025.0%4.08.00.033.3%6.014.00.030.0%11.019.00.036.7%11.019.00.036.7%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Hofseth BioCare ASA compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.0100.001-932%0.001-742%-0.001-93%0.000-2142%
Book Value Per Share--0.0140.026-46%0.004+242%0.023-39%0.017-18%
Current Ratio--0.6650.815-18%0.697-5%1.180-44%1.208-45%
Debt To Asset Ratio--0.8200.696+18%0.772+6%0.663+24%0.677+21%
Debt To Equity Ratio--4.5182.586+75%4.140+9%2.441+85%2.484+82%
Dividend Per Share----0%-0%-0%-0%
Enterprise Value--17133346.00047992207.400-64%321398294.449-95%246188554.408-93%246188554.408-93%
Eps---0.010-0.007-26%-0.002-75%-0.006-36%-0.005-52%
Ev To Ebitda Ratio---1.707-12.755+647%-686.568+40113%-185.977+10793%-185.977+10793%
Ev To Sales Ratio--0.6972.003-65%179.755-100%78.521-99%78.521-99%
Free Cash Flow Per Share--0.000-0.003+3369%-0.002+2178%-0.004+4318%-0.004+4318%
Free Cash Flow To Equity Per Share--0.0010.000+420%0.000+13%-0.001+212%-0.001+212%
Gross Profit Margin--1.0001.0000%1.065-6%1.013-1%1.009-1%
Intrinsic Value_10Y_max--0.256--------
Intrinsic Value_10Y_min--0.210--------
Intrinsic Value_1Y_max---0.003--------
Intrinsic Value_1Y_min---0.003--------
Intrinsic Value_3Y_max--0.012--------
Intrinsic Value_3Y_min--0.011--------
Intrinsic Value_5Y_max--0.054--------
Intrinsic Value_5Y_min--0.048--------
Market Cap63716780.000+35%41208100.00069961236.350-41%330916180.000-88%262611012.070-84%175074008.047-76%
Net Profit Margin---0.644-0.484-25%-0.581-10%-1.158+80%-1.202+87%
Operating Margin---0.572-0.426-26%-1.210+111%-1.180+106%-1.183+107%
Operating Ratio--1.0001.249-20%1.680-40%2.352-57%2.575-61%
Pb Ratio11.014+35%7.1066.636+7%330.533-98%98.062-93%65.374-89%
Pe Ratio-4.036-55%-2.604-6.894+165%-34.900+1240%-25.677+886%-17.118+557%
Price Per Share0.155+35%0.1000.170-41%0.805-88%0.639-84%0.426-77%
Price To Free Cash Flow Ratio-457.443-55%-295.124-415.247+41%2317.921-113%338.191-187%225.461-231%
Price To Total Gains Ratio-16.181-55%-10.440-16.938+62%9588.342-100%1869.240-101%1869.240-101%
Quick Ratio--0.2640.270-2%0.351-25%0.228+16%0.196+35%
Return On Assets---0.123-0.085-31%-0.068-44%-0.078-37%-0.084-31%
Return On Equity---0.675-0.331-51%-0.441-35%-0.291-57%-0.311-54%
Total Gains Per Share---0.0100.001-932%0.001-742%-0.001-93%0.000-2142%
Usd Book Value--5799358.40010822027.150-46%1691844.043+243%9511865.968-39%8458306.839-31%
Usd Book Value Change Per Share---0.0100.001-932%0.001-742%-0.001-93%0.000-2142%
Usd Book Value Per Share--0.0140.026-46%0.004+242%0.023-39%0.017-18%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Enterprise Value--17133346.00047992207.400-64%321398294.449-95%246188554.408-93%246188554.408-93%
Usd Eps---0.010-0.007-26%-0.002-75%-0.006-36%-0.005-52%
Usd Free Cash Flow---34907.400-1209626.550+3365%-793093.077+2172%-1538771.479+4308%-1025847.653+2839%
Usd Free Cash Flow Per Share--0.000-0.003+3369%-0.002+2178%-0.004+4318%-0.004+4318%
Usd Free Cash Flow To Equity Per Share--0.0010.000+420%0.000+13%-0.001+212%-0.001+212%
Usd Market Cap63716780.000+35%41208100.00069961236.350-41%330916180.000-88%262611012.070-84%175074008.047-76%
Usd Price Per Share0.155+35%0.1000.170-41%0.805-88%0.639-84%0.426-77%
Usd Profit---3956455.800-2918528.250-26%-1350206.383-66%-2160059.850-45%-2067231.594-48%
Usd Revenue--6146540.4006275929.550-2%1407153.786+337%2465413.979+149%2218982.286+177%
Usd Total Gains Per Share---0.0100.001-932%0.001-742%-0.001-93%0.000-2142%
 EOD+5 -3MRQTTM+9 -28YOY+15 -235Y+14 -2410Y+14 -24

3.3 Fundamental Score

Let's check the fundamental score of Hofseth BioCare ASA based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-4.036
Price to Book Ratio (EOD)Between0-111.014
Net Profit Margin (MRQ)Greater than0-0.644
Operating Margin (MRQ)Greater than0-0.572
Quick Ratio (MRQ)Greater than10.264
Current Ratio (MRQ)Greater than10.665
Debt to Asset Ratio (MRQ)Less than10.820
Debt to Equity Ratio (MRQ)Less than14.518
Return on Equity (MRQ)Greater than0.15-0.675
Return on Assets (MRQ)Greater than0.05-0.123
Total1/10 (10.0%)

3.4 Technical Score

Let's check the technical score of Hofseth BioCare ASA based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5099.968
Ma 20Greater thanMa 500.106
Ma 50Greater thanMa 1000.102
Ma 100Greater thanMa 2000.101
OpenGreater thanClose0.155
Total3/5 (60.0%)

4. In-depth Analysis

4.1 About Hofseth BioCare ASA

Hofseth BioCare ASA operates as a consumer and pet health ingredient supplier and incubator in Norway, the United Kingdom, France, Belgium, Europe, Japan, Asia, and the United States. The company's products include OmeGo, a salmon oil, which offers the full spectrum of fatty acids and omegas found naturally in fresh whole salmon; ProGo, a bioactive peptide for VMS, metabolism, and active nutrition needs; CalGo, an absorbable complex mineral for bone and joint health; CollaGo; and PetGo, a non-soluble protein. The company was incorporated in 2000 and is headquartered in Ålesund, Norway.

Fundamental data was last updated by Penke on 2025-04-05 02:45:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Hofseth BioCare ASA earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Hofseth BioCare ASA to the Biotechnology industry mean.
  • A Net Profit Margin of -64.4% means that $-0.64 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Hofseth BioCare ASA:

  • The MRQ is -64.4%. The company is making a huge loss. -2
  • The TTM is -48.4%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-64.4%TTM-48.4%-16.0%
TTM-48.4%YOY-58.1%+9.8%
TTM-48.4%5Y-115.8%+67.5%
5Y-115.8%10Y-120.2%+4.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-64.4%-99.7%+35.3%
TTM-48.4%-188.1%+139.7%
YOY-58.1%-199.6%+141.5%
5Y-115.8%-357.6%+241.8%
10Y-120.2%-488.5%+368.3%
4.3.1.2. Return on Assets

Shows how efficient Hofseth BioCare ASA is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Hofseth BioCare ASA to the Biotechnology industry mean.
  • -12.3% Return on Assets means that Hofseth BioCare ASA generated $-0.12 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Hofseth BioCare ASA:

  • The MRQ is -12.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -8.5%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-12.3%TTM-8.5%-3.8%
TTM-8.5%YOY-6.8%-1.6%
TTM-8.5%5Y-7.8%-0.7%
5Y-7.8%10Y-8.4%+0.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-12.3%-12.3%+0.0%
TTM-8.5%-12.2%+3.7%
YOY-6.8%-12.0%+5.2%
5Y-7.8%-13.4%+5.6%
10Y-8.4%-15.3%+6.9%
4.3.1.3. Return on Equity

Shows how efficient Hofseth BioCare ASA is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Hofseth BioCare ASA to the Biotechnology industry mean.
  • -67.5% Return on Equity means Hofseth BioCare ASA generated $-0.67 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Hofseth BioCare ASA:

  • The MRQ is -67.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -33.1%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-67.5%TTM-33.1%-34.3%
TTM-33.1%YOY-44.1%+11.0%
TTM-33.1%5Y-29.1%-4.0%
5Y-29.1%10Y-31.1%+2.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-67.5%-16.1%-51.4%
TTM-33.1%-16.2%-16.9%
YOY-44.1%-15.8%-28.3%
5Y-29.1%-19.5%-9.6%
10Y-31.1%-21.7%-9.4%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Hofseth BioCare ASA.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Hofseth BioCare ASA is operating .

  • Measures how much profit Hofseth BioCare ASA makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Hofseth BioCare ASA to the Biotechnology industry mean.
  • An Operating Margin of -57.2% means the company generated $-0.57  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Hofseth BioCare ASA:

  • The MRQ is -57.2%. The company is operating very inefficient. -2
  • The TTM is -42.6%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-57.2%TTM-42.6%-14.7%
TTM-42.6%YOY-121.0%+78.4%
TTM-42.6%5Y-118.0%+75.4%
5Y-118.0%10Y-118.3%+0.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-57.2%-188.3%+131.1%
TTM-42.6%-291.0%+248.4%
YOY-121.0%-214.8%+93.8%
5Y-118.0%-368.2%+250.2%
10Y-118.3%-471.9%+353.6%
4.3.2.2. Operating Ratio

Measures how efficient Hofseth BioCare ASA is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.00 means that the operating costs are $1.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Hofseth BioCare ASA:

  • The MRQ is 1.000. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.249. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.000TTM1.249-0.249
TTM1.249YOY1.680-0.431
TTM1.2495Y2.352-1.103
5Y2.35210Y2.575-0.223
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0002.233-1.233
TTM1.2493.152-1.903
YOY1.6803.084-1.404
5Y2.3525.091-2.739
10Y2.5756.520-3.945
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Hofseth BioCare ASA.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Hofseth BioCare ASA is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.67 means the company has $0.67 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Hofseth BioCare ASA:

  • The MRQ is 0.665. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.815. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ0.665TTM0.815-0.150
TTM0.815YOY0.697+0.118
TTM0.8155Y1.180-0.365
5Y1.18010Y1.208-0.028
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6653.616-2.951
TTM0.8153.893-3.078
YOY0.6974.280-3.583
5Y1.1805.791-4.611
10Y1.2086.182-4.974
4.4.3.2. Quick Ratio

Measures if Hofseth BioCare ASA is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Hofseth BioCare ASA to the Biotechnology industry mean.
  • A Quick Ratio of 0.26 means the company can pay off $0.26 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Hofseth BioCare ASA:

  • The MRQ is 0.264. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.270. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.264TTM0.270-0.007
TTM0.270YOY0.351-0.080
TTM0.2705Y0.228+0.042
5Y0.22810Y0.196+0.032
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2642.920-2.656
TTM0.2703.417-3.147
YOY0.3514.170-3.819
5Y0.2285.727-5.499
10Y0.1966.469-6.273
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Hofseth BioCare ASA.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Hofseth BioCare ASA assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Hofseth BioCare ASA to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.82 means that Hofseth BioCare ASA assets are financed with 82.0% credit (debt) and the remaining percentage (100% - 82.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Hofseth BioCare ASA:

  • The MRQ is 0.820. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.696. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.820TTM0.696+0.125
TTM0.696YOY0.772-0.076
TTM0.6965Y0.663+0.032
5Y0.66310Y0.677-0.014
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8200.344+0.476
TTM0.6960.344+0.352
YOY0.7720.332+0.440
5Y0.6630.359+0.304
10Y0.6770.384+0.293
4.5.4.2. Debt to Equity Ratio

Measures if Hofseth BioCare ASA is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Hofseth BioCare ASA to the Biotechnology industry mean.
  • A Debt to Equity ratio of 451.8% means that company has $4.52 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Hofseth BioCare ASA:

  • The MRQ is 4.518. The company is unable to pay all its debts with equity. -1
  • The TTM is 2.586. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ4.518TTM2.586+1.932
TTM2.586YOY4.140-1.554
TTM2.5865Y2.441+0.145
5Y2.44110Y2.484-0.043
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.5180.407+4.111
TTM2.5860.427+2.159
YOY4.1400.402+3.738
5Y2.4410.448+1.993
10Y2.4840.493+1.991
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Hofseth BioCare ASA generates.

  • Above 15 is considered overpriced but always compare Hofseth BioCare ASA to the Biotechnology industry mean.
  • A PE ratio of -2.60 means the investor is paying $-2.60 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Hofseth BioCare ASA:

  • The EOD is -4.036. Based on the earnings, the company is expensive. -2
  • The MRQ is -2.604. Based on the earnings, the company is expensive. -2
  • The TTM is -6.894. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.036MRQ-2.604-1.432
MRQ-2.604TTM-6.894+4.291
TTM-6.894YOY-34.900+28.006
TTM-6.8945Y-25.677+18.783
5Y-25.67710Y-17.118-8.559
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-4.036-1.809-2.227
MRQ-2.604-2.564-0.040
TTM-6.894-3.191-3.703
YOY-34.900-3.323-31.577
5Y-25.677-6.424-19.253
10Y-17.118-7.149-9.969
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Hofseth BioCare ASA:

  • The EOD is -457.443. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -295.124. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -415.247. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-457.443MRQ-295.124-162.318
MRQ-295.124TTM-415.247+120.123
TTM-415.247YOY2,317.921-2,733.168
TTM-415.2475Y338.191-753.438
5Y338.19110Y225.461+112.730
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-457.443-2.461-454.982
MRQ-295.124-3.566-291.558
TTM-415.247-3.951-411.296
YOY2,317.921-4.482+2,322.403
5Y338.191-8.693+346.884
10Y225.461-9.796+235.257
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Hofseth BioCare ASA is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 7.11 means the investor is paying $7.11 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Hofseth BioCare ASA:

  • The EOD is 11.014. Based on the equity, the company is expensive. -2
  • The MRQ is 7.106. Based on the equity, the company is overpriced. -1
  • The TTM is 6.636. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD11.014MRQ7.106+3.908
MRQ7.106TTM6.636+0.470
TTM6.636YOY330.533-323.897
TTM6.6365Y98.062-91.426
5Y98.06210Y65.374+32.687
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD11.0141.676+9.338
MRQ7.1062.283+4.823
TTM6.6362.457+4.179
YOY330.5332.507+328.026
5Y98.0623.773+94.289
10Y65.3744.321+61.053
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-12-31. Currency in NOK. All numbers in thousands.

Summary
Total Assets341,371
Total Liabilities280,067
Total Stockholder Equity61,993
 As reported
Total Liabilities 280,067
Total Stockholder Equity+ 61,993
Total Assets = 341,371

Assets

Total Assets341,371
Total Current Assets112,062
Long-term Assets229,309
Total Current Assets
Cash And Cash Equivalents 25,577
Net Receivables 18,853
Inventory 55,917
Total Current Assets  (as reported)112,062
Total Current Assets  (calculated)100,347
+/- 11,715
Long-term Assets
Property Plant Equipment 137,983
Intangible Assets 42,430
Long-term Assets Other 48,896
Long-term Assets  (as reported)229,309
Long-term Assets  (calculated)229,309
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities168,424
Long-term Liabilities111,643
Total Stockholder Equity61,993
Total Current Liabilities
Accounts payable 93,629
Other Current Liabilities 74,795
Total Current Liabilities  (as reported)168,424
Total Current Liabilities  (calculated)168,424
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)111,643
Long-term Liabilities  (calculated)0
+/- 111,643
Total Stockholder Equity
Common Stock4,111
Other Stockholders Equity 57,882
Total Stockholder Equity (as reported)61,993
Total Stockholder Equity (calculated)61,993
+/-0
Other
Capital Stock4,111
Cash and Short Term Investments 25,577
Common Stock Shares Outstanding 412,081
Liabilities and Stockholders Equity 341,371
Net Debt -25,577
Net Invested Capital 61,993
Net Working Capital -56,362
Property Plant and Equipment Gross 137,983



6.2. Balance Sheets Structured

Currency in NOK. All numbers in thousands.

 Trend2024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-30
> Total Assets 
150,790
184,239
151,709
151,209
196,064
187,945
245,098
228,896
330,540
293,012
293,669
306,872
293,288
459,134
443,339
458,119
443,342
415,973
397,917
38,218
38,695
42,003
37,347
38,244
37,553
390,119
390,714
385,528
365,314
341,371
341,371365,314385,528390,714390,11937,55338,24437,34742,00338,69538,218397,917415,973443,342458,119443,339459,134293,288306,872293,669293,012330,540228,896245,098187,945196,064151,209151,709184,239150,790
   > Total Current Assets 
63,692
94,891
63,183
55,328
103,223
100,318
91,850
81,423
176,160
137,853
139,560
141,899
106,801
271,470
250,343
228,240
198,130
170,311
154,918
14,078
16,835
17,918
15,125
14,582
13,731
131,003
138,785
135,825
125,324
112,062
112,062125,324135,825138,785131,00313,73114,58215,12517,91816,83514,078154,918170,311198,130228,240250,343271,470106,801141,899139,560137,853176,16081,42391,850100,318103,22355,32863,18394,89163,692
       Cash And Cash Equivalents 
29,778
42,068
23,792
10,514
58,047
48,641
36,517
19,868
109,362
93,211
67,446
60,997
23,769
170,712
138,535
112,573
85,506
47,211
30,572
574
4,244
3,306
2,181
1,556
1,651
23,890
22,155
25,302
23,379
25,577
25,57723,37925,30222,15523,8901,6511,5562,1813,3064,24457430,57247,21185,506112,573138,535170,71223,76960,99767,44693,211109,36219,86836,51748,64158,04710,51423,79242,06829,778
       Net Receivables 
4,702
33,265
6,499
11,146
5,308
17,661
12,480
8,490
6,682
5,561
13,087
14,733
7,285
21,083
16,957
17,765
11,218
23,458
18,639
1,827
1,313
1,435
1,515
1,710
16,285
14,849
23,406
26,999
28,788
18,853
18,85328,78826,99923,40614,84916,2851,7101,5151,4351,3131,82718,63923,45811,21817,76516,95721,0837,28514,73313,0875,5616,6828,49012,48017,6615,30811,1466,49933,2654,702
       Inventory 
19,772
16,858
20,579
23,753
24,405
29,402
35,849
42,478
31,987
33,986
45,655
54,883
64,479
73,302
85,285
87,238
88,976
90,813
92,714
10,279
10,004
11,880
10,380
10,249
9,488
82,542
83,715
72,450
63,307
55,917
55,91763,30772,45083,71582,5429,48810,24910,38011,88010,00410,27992,71490,81388,97687,23885,28573,30264,47954,88345,65533,98631,98742,47835,84929,40224,40523,75320,57916,85819,772
       Other Current Assets 
9,440
0
12,313
9,915
15,463
2,022
7,004
296
1
1,494
13,372
11,286
11,268
11,792
9,566
10,664
12,430
4,509
12,993
1,398
1,274
1,298
1,049
1,066
11,855
9,722
9,509
11,074
38,638
30,568
30,56838,63811,0749,5099,72211,8551,0661,0491,2981,2741,39812,9934,50912,43010,6649,56611,79211,26811,28613,3721,49412967,0042,02215,4639,91512,31309,440
   > Long-term Assets 
0
0
0
0
0
0
153,248
147,473
154,380
155,160
154,109
164,973
186,487
187,664
192,996
229,879
245,212
245,662
243,000
24,140
21,860
24,085
22,221
23,662
23,822
259,116
251,929
249,703
239,989
229,309
229,309239,989249,703251,929259,11623,82223,66222,22124,08521,86024,140243,000245,662245,212229,879192,996187,664186,487164,973154,109155,160154,380147,473153,248000000
       Property Plant Equipment 
70,957
68,088
67,603
74,622
70,652
67,361
133,623
127,527
130,600
128,353
126,983
131,316
141,223
137,955
141,643
175,509
188,225
185,832
183,457
17,959
15,867
17,209
15,658
14,918
14,635
165,703
160,650
152,658
145,598
137,983
137,983145,598152,658160,650165,70314,63514,91815,65817,20915,86717,959183,457185,832188,225175,509141,643137,955141,223131,316126,983128,353130,600127,527133,62367,36170,65274,62267,60368,08870,957
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
48,976
0
0
55,965
52,140
51,156
1
0
0
0
0
0000151,15652,14055,9650048,9760000000000000000000
       Long Term Investments 
746
3,654
3,654
4,072
5,215
2,909
2,681
3,447
1,788
1,734
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000001,7341,7883,4472,6812,9095,2154,0723,6543,654746
       Intangible Assets 
2,265
1,948
17,269
17,186
16,974
1,390
16,874
16,428
21,991
24,347
24,427
33,205
38,295
42,434
44,020
47,971
50,388
53,130
52,918
5,495
5,364
6,177
5,906
5,350
5,272
55,284
53,916
45,742
44,322
42,430
42,43044,32245,74253,91655,2845,2725,3505,9066,1775,3645,49552,91853,13050,38847,97144,02042,43438,29533,20524,42724,34721,99116,42816,8741,39016,97417,18617,2691,9482,265
       Long-term Assets Other 
0
0
0
0
0
0
1,409
1,411
1
155,160
1,757
-456
573
54
0
-457
-257
-75
-74
6,907
6,907
-5
1
1,999
-51,120
-2
53,916
46,501
50,069
48,896
48,89650,06946,50153,916-2-51,1201,9991-56,9076,907-74-75-257-457054573-4561,757155,16011,4111,409000000
> Total Liabilities 
100,811
147,156
136,794
155,127
86,394
101,901
178,306
180,358
186,020
175,262
170,880
203,397
217,824
195,370
205,625
244,239
267,105
275,595
289,906
30,361
21,618
26,812
26,594
27,386
28,766
348,979
235,047
247,981
262,241
280,067
280,067262,241247,981235,047348,97928,76627,38626,59426,81221,61830,361289,906275,595267,105244,239205,625195,370217,824203,397170,880175,262186,020180,358178,306101,90186,394155,127136,794147,156100,811
   > Total Current Liabilities 
68,848
102,813
93,898
113,453
53,012
71,514
82,791
88,635
75,858
71,753
61,365
109,276
125,164
106,179
119,578
126,974
138,203
150,933
168,918
15,721
13,115
17,558
18,108
19,028
20,557
251,877
139,358
155,521
172,503
168,424
168,424172,503155,521139,358251,87720,55719,02818,10817,55813,11515,721168,918150,933138,203126,974119,578106,179125,164109,27661,36571,75375,85888,63582,79171,51453,012113,45393,898102,81368,848
       Short-term Debt 
8,466
4,672
23,131
0
0
0
0
0
27,611
21,979
0
0
0
0
0
0
0
0
0
1,466
1,280
1,366
1,157
1,072
-187,868
183,687
66,899
85,061
0
0
0085,06166,899183,687-187,8681,0721,1571,3661,2801,46600000000021,97927,6110000023,1314,6728,466
       Short Long Term Debt 
8,466
4,672
23,131
32,853
22,784
6,104
30,245
29,770
27,611
21,979
0
0
0
3,428
11,652
0
0
2,420
14,617
14,531
0
540
0
0
0
172,893
0
0
0
0
0000172,893000540014,53114,6172,4200011,6523,42800021,97927,61129,77030,2456,10422,78432,85323,1314,6728,466
       Accounts payable 
55,311
51,929
51,164
77,379
23,099
32,112
44,494
56,431
39,602
29,712
45,018
49,656
63,648
84,956
98,338
104,979
116,995
124,165
142,917
13,536
11,095
14,859
15,916
17,514
201,145
55,161
60,441
70,460
66,657
93,629
93,62966,65770,46060,44155,161201,14517,51415,91614,85911,09513,536142,917124,165116,995104,97998,33884,95663,64849,65645,01829,71239,60256,43144,49432,11223,09977,37951,16451,92955,311
       Other Current Liabilities 
5,071
13,800
19,603
3,221
7,129
6,081
8,052
2,434
8,645
2,975
11,262
9,666
11,858
10,251
9,588
10,752
9,965
12,600
11,384
719
740
1,334
1,035
442
-181,674
13,029
12,018
7,960
105,846
74,795
74,795105,8467,96012,01813,029-181,6744421,0351,33474071911,38412,6009,96510,7529,58810,25111,8589,66611,2622,9758,6452,4348,0526,0817,1293,22119,60313,8005,071
   > Long-term Liabilities 
0
0
0
0
0
0
95,515
91,723
110,162
103,509
109,515
94,142
92,660
89,191
86,047
117,265
128,902
124,662
120,988
14,639
8,503
9,254
8,486
8,358
8,210
97,102
95,689
92,460
89,738
111,643
111,64389,73892,46095,68997,1028,2108,3588,4869,2548,50314,639120,988124,662128,902117,26586,04789,19192,66094,142109,515103,509110,16291,72395,515000000
       Capital Lease Obligations 
0
0
0
0
0
0
0
0
0
81,971
0
0
0
72,302
0
0
0
112,977
0
0
0
102,815
0
0
0
107,625
0
0
0
0
0000107,625000102,815000112,97700072,30200081,971000000000
       Other Liabilities 
0
1
1
0
0
-1
0
-1
0
-1
-1
0
-1
-1
0
0
0
-1
0
1
-1
-1
0
-1
0
0
0
0
0
0
000000-10-1-110-1000-1-10-1-10-10-100110
> Total Stockholder Equity
50,637
37,748
15,580
-3,253
110,335
86,717
67,465
49,211
145,193
118,432
123,471
104,158
76,147
264,448
238,398
214,564
176,921
141,063
108,696
7,927
17,141
15,260
10,818
10,921
8,851
41,827
156,354
138,234
103,760
61,993
61,993103,760138,234156,35441,8278,85110,92110,81815,26017,1417,927108,696141,063176,921214,564238,398264,44876,147104,158123,471118,432145,19349,21167,46586,717110,335-3,25315,58037,74850,637
   Common Stock
233,500
233,500
233,500
233,500
294,837
294,837
294,837
294,837
324,321
325,821
329,074
3,291
3,302
3,578
3,578
3,578
3,578
3,578
3,578
361
363
403
377
368
369
3,951
4,113
4,113
4,113
4,111
4,1114,1134,1134,1133,9513693683774033633613,5783,5783,5783,5783,5783,5783,3023,291329,074325,821324,321294,837294,837294,837294,837233,500233,500233,500233,500
   Retained Earnings 
-182,863
-195,752
-217,919
-236,753
-184,502
-208,120
-227,372
-245,626
-179,128
-208,216
-205,603
100,867
72,845
15,477
234,820
210,986
173,343
139,185
105,118
7,566
16,778
14,857
10,441
10,554
8,482
37,876
152,241
134,121
0
0
00134,121152,24137,8768,48210,55410,44114,85716,7787,566105,118139,185173,343210,986234,82015,47772,845100,867-205,603-208,216-179,128-245,626-227,372-208,120-184,502-236,753-217,919-195,752-182,863
   Capital Surplus 000000000000000000000000000000
   Treasury Stock000000000000000000000000000000
   Other Stockholders Equity 
0
0
-1
0
0
0
0
0
0
827
0
0
0
8,684
0
0
0
0
0
0
-363
-403
-377
-368
-90,793
37,876
-152,241
-134,121
99,647
57,882
57,88299,647-134,121-152,24137,876-90,793-368-377-403-3630000008,684000827000000-100



6.3. Balance Sheets

Currency in NOK. All numbers in thousands.




6.4. Cash Flows

Currency in NOK. All numbers in thousands.




6.5. Income Statements

Currency in NOK. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in NOK. All numbers in thousands.

Gross Profit (+$)
totalRevenue257,417
Cost of Revenue-169,553
Gross Profit87,86487,864
 
Operating Income (+$)
Gross Profit87,864
Operating Expense-87,864
Operating Income-113,2040
 
Operating Expense (+$)
Research Development-
Selling General Administrative-
Selling And Marketing Expenses-
Operating Expense87,8640
 
Net Interest Income (+$)
Interest Income790
Interest Expense-15,685
Other Finance Cost-0
Net Interest Income-14,895
 
Pretax Income (+$)
Operating Income-113,204
Net Interest Income-14,895
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-123,40710,203
EBIT - interestExpense = -123,407
-123,405
-107,720
Interest Expense15,685
Earnings Before Interest and Taxes (EBIT)-107,722-107,722
Earnings Before Interest and Taxes (EBITDA)-67,941
 
After tax Income (+$)
Income Before Tax-123,407
Tax Provision-0
Net Income From Continuing Ops-123,407-123,407
Net Income-123,405
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses257,417
Total Other Income/Expenses Net-123,40714,895
 

Technical Analysis of Hofseth BioCare ASA
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Hofseth BioCare ASA. The general trend of Hofseth BioCare ASA is BULLISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Hofseth BioCare ASA's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (42.9%) Bearish trend (-42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Hofseth BioCare ASA Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Hofseth BioCare ASA.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.17 < 0.17 < 0.17.

The bearish price targets are: 0.1 > 0.1 > 0.1.

Know someone who trades $HOFBF? Share this with them.👇

Hofseth BioCare ASA Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Hofseth BioCare ASA. The current mas is .

The long score for the Moving Averages is 10/14.
The longshort score for the Moving Averages is 6/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Hofseth BioCare ASA Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Hofseth BioCare ASA. The current macd is 0.00776383.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Hofseth BioCare ASA price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Hofseth BioCare ASA. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Hofseth BioCare ASA price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Hofseth BioCare ASA Daily Moving Average Convergence/Divergence (MACD) ChartHofseth BioCare ASA Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Hofseth BioCare ASA. The current adx is 99.20.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Hofseth BioCare ASA shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Hofseth BioCare ASA Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Hofseth BioCare ASA. The current sar is 0.1.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Hofseth BioCare ASA Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Hofseth BioCare ASA. The current rsi is 99.97. The current phase is Overbought in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -1/(-13 +13).

  • Overbought in bull market: Short-term excessive buying, potential for pullback. Consider taking profits, be cautious of potential correction. -1
Hofseth BioCare ASA Daily Relative Strength Index (RSI) ChartHofseth BioCare ASA Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Hofseth BioCare ASA. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 5/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Hofseth BioCare ASA price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
Hofseth BioCare ASA Daily Stochastic Oscillator ChartHofseth BioCare ASA Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Hofseth BioCare ASA. The current cci is 333.33.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Hofseth BioCare ASA Daily Commodity Channel Index (CCI) ChartHofseth BioCare ASA Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Hofseth BioCare ASA. The current cmo is 100.00.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Hofseth BioCare ASA Daily Chande Momentum Oscillator (CMO) ChartHofseth BioCare ASA Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Hofseth BioCare ASA. The current willr is 0.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Hofseth BioCare ASA Daily Williams %R ChartHofseth BioCare ASA Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Hofseth BioCare ASA.

Hofseth BioCare ASA Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Hofseth BioCare ASA. The current atr is 0.00404558.

Hofseth BioCare ASA Daily Average True Range (ATR) ChartHofseth BioCare ASA Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Hofseth BioCare ASA. The current obv is -92,420.

Hofseth BioCare ASA Daily On-Balance Volume (OBV) ChartHofseth BioCare ASA Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Hofseth BioCare ASA. The current mfi is 100.00.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
Hofseth BioCare ASA Daily Money Flow Index (MFI) ChartHofseth BioCare ASA Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Hofseth BioCare ASA.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-11-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-12-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-12-09MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-12-18WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-12-25CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-01-01CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-01-09CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-01-20CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-02-07WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-02-17CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-03-07WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside

6.3. Candlestick Patterns

Hofseth BioCare ASA Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Hofseth BioCare ASA based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5099.968
Ma 20Greater thanMa 500.106
Ma 50Greater thanMa 1000.102
Ma 100Greater thanMa 2000.101
OpenGreater thanClose0.155
Total3/5 (60.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Hofseth BioCare ASA with someone you think should read this too:
  • Are you bullish or bearish on Hofseth BioCare ASA? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Hofseth BioCare ASA? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Hofseth BioCare ASA

I send you an email if I find something interesting about Hofseth BioCare ASA.


Comments

How you think about this?

Leave a comment

Stay informed about Hofseth BioCare ASA.

Receive notifications about Hofseth BioCare ASA in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.